Published

Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Psychopharmacology
Date: 2026-07-16
Source: Crossref
DOI: 10.1177/02698811261464988
PubMed: 42460632

Authors

Dougherty Robert F.Modlin Nadav Liam McGowan Niall M.Staples Patrick Williams Ella Clarke Patrick Shafiei Mario Leininger Carly Alti Merve Croal Megan Marwood Lindsey Kirlić Namik Ryslik Gregory A.Goodwin Guy M.

Watch author

Derived topics and classifications

psilocybin PTSD Consciousness Clinical Trial Drug Interactions Clinical Trial

Citation graph

25 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1007/978-3-031-13942-0_2 10.5539/ijps.v8n3p134 10.1056/nejmoa2032994 10.1038/npp.2017.84 10.1016/s2215-0366(16)30065-7 10.1016/j.jad.2018.01.006 10.1001/jamapsychiatry.2020.3285 10.1055/s-2007-979351 10.1007/s00213-023-06432-5 10.1056/nejmoa2206443 10.1176/appi.ajp.20221043 10.1016/j.jad.2024.12.061

Indexed papers citing this DOI

Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder2026-07-16

Related papers

A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-09-04 PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13 Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress DisorderClinicalTrials.gov · 2026-07-30 A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-06-25 Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolenceClinicalTrials.gov · 2026-09-08 Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-09-04 Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility StudyClinicalTrials.gov · 2026-08-28 Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand MechanismClinicalTrials.gov · 2026-08-06